177 related articles for article (PubMed ID: 6111836)
1. [Treatment of bronchial obstruction with beta-2-mimetic and anticholinergic agents in aerosol. Advantages of the combination of both groups of pharmaceuticals].
Minette A; Marcq M
Rev Inst Hyg Mines (Hasselt); 1980; 35(2):85-114. PubMed ID: 6111836
[TBL] [Abstract][Full Text] [Related]
2. Oxitropium bromide (Ba 253), an advance in the field of anticholinergic bronchodilating treatments. Preliminary results.
Minette A; Marcq M
Rev Inst Hyg Mines (Hasselt); 1979; 34(3):115-23. PubMed ID: 45210
[TBL] [Abstract][Full Text] [Related]
3. [The bronchodilator effect of aerosol beta-2-mimetic and anticholinergic agents in patients with chronic bronchitis].
Vestri R; Philip-Joet F; Reynaud-Gaubert M; Arnaud A
Rev Mal Respir; 1990; 7(1):59-63. PubMed ID: 2251437
[TBL] [Abstract][Full Text] [Related]
4. [Inhalation therapy in chronic obstructive bronchial diseases].
Barandun J
Schweiz Med Wochenschr; 1996 Oct; 126(40):1693-703. PubMed ID: 8966503
[TBL] [Abstract][Full Text] [Related]
5. [The treatment of bronchiolar obstruction (author's transl)].
Cornia G; Gramiccioni E; Mannino F
MMW Munch Med Wochenschr; 1974 Dec; 116(51-52):2243-6. PubMed ID: 4155789
[No Abstract] [Full Text] [Related]
6. Bronchodilator resuscitation in the emergency department. Part 2 of 2: dosing strategies.
Fink J; Dhand R
Respir Care; 2000 May; 45(5):497-512. PubMed ID: 10813227
[No Abstract] [Full Text] [Related]
7. How should a pressurized beta-adrenergic bronchodilator be inhaled?
Newman SP; Pavia D; Clarke SW
Eur J Respir Dis; 1981 Feb; 62(1):3-21. PubMed ID: 6112156
[TBL] [Abstract][Full Text] [Related]
8. [Clinical pharmacological trials of a new metered dose inhaler, IK-6, a combination of the bronchodilators fenoterol and ipratropium bromide (author's transl)].
Kaik G; Kaik B; Laggner A
Wien Med Wochenschr; 1980 Jun; 130(11):385-93. PubMed ID: 6449783
[TBL] [Abstract][Full Text] [Related]
9. The labelling and monitoring of lung deposition of an inhaled synthetic anticholinergic bronchodilating agent.
Short MD; Singh CA; Few JD; Studdy PR; Heaf PJ; Spiro SG
Chest; 1981 Dec; 80(6 Suppl):918-21. PubMed ID: 6458460
[No Abstract] [Full Text] [Related]
10. [Combined bronchodilating therapy of respiratory diseases complicated with bronchial obstruction].
Shmelev EI
Ter Arkh; 2007; 79(3):17-21. PubMed ID: 17526189
[No Abstract] [Full Text] [Related]
11. [The new anticholinergic bronchospasmolytic oxitropium bromide. Is long lasting protective effect through the night].
Kneubühler HR; Kyd K; Benoit RC; Scherrer M
Schweiz Med Wochenschr; 1980 May; 110(21):812-6. PubMed ID: 7394499
[TBL] [Abstract][Full Text] [Related]
12. [Bronchodilator effects of an atropinic compound: oxitropium pressurized aerosol. Comparison with theophylline in asthma].
Gayrard P; Orehek J
Rev Pneumol Clin; 1984; 40(4):273-4. PubMed ID: 6545469
[TBL] [Abstract][Full Text] [Related]
13. Oral salbutamol as a supplement too inhaled aerosol in obstructive respiratory disease.
Vale JR
Scand J Respir Dis; 1971; 52(1):58-62. PubMed ID: 4398035
[No Abstract] [Full Text] [Related]
14. [Bronchial obstruction and its differentiated therapy in bronchopulmonary diseases].
Zamotaev IP; Shul'gin AV; Maksimova LN; Bulycheva NA; Golub' GA
Sov Med; 1977 Dec; (12):19-23. PubMed ID: 23586
[No Abstract] [Full Text] [Related]
15. [New developments in the field of bronchospasmolytics].
Nolte D
Fortschr Med; 1979 Jan; 97(3):89-95. PubMed ID: 33884
[TBL] [Abstract][Full Text] [Related]
16. Combination therapy with anticholinergic agents for airflow obstruction.
Boushey HA
Postgrad Med J; 1987; 63 Suppl 1():69-74. PubMed ID: 3122192
[TBL] [Abstract][Full Text] [Related]
17. [Effects of a beta-adrenergic stimulant: Salbutamol, on spontaneous or induced bronchial obstruction in asthma].
Orehek J; Gayrard P; Charpin J
Mars Med; 1972; 109(11):713-7. PubMed ID: 4145413
[No Abstract] [Full Text] [Related]
18. Adrenergic agonists and bronchodilator aerosol therapy in asthma.
Shim C
Clin Chest Med; 1984 Dec; 5(4):659-68. PubMed ID: 6151440
[TBL] [Abstract][Full Text] [Related]
19. [Current dosed aerosols in the treatment of obstructive airway diseases. 2. Bronchospasmolytics].
Krecklow B
Z Arztl Fortbild (Jena); 1984; 78(1):5-9. PubMed ID: 6231780
[No Abstract] [Full Text] [Related]
20. [Effects of aerosol oxitropium bromide and fenoterol on maximal exercise capacity in chronic obstructive pulmonary disease and their correlation with air flow during exercise and with parameters of maximal exercise].
Suruda T; Nakamura H; Kobayashi H; Uetani K; Nishio M; Higashimoto Y; Funasako M; Ohata M
Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Sep; 31(9):1089-95. PubMed ID: 8255017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
